ArticleBMC genomics2026
A regulatory network underlying glume hardness revealed by transcriptomic analysis of an ems-induced mutant in synthetic hexaploid wheat.
Article in BMC genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTenacious glume a key trait limiting threshing efficiency in synthetic hexaploid wheat (SHW), represents an ancestral defense mechanism inherited from wild progenitors. Despite its evolutionary importance, the molecular basis of this domestication-associated trait remains poorly understood. To address this, we performed a comprehensive transcriptomic analysis of developing spikes from wild-type (tenacious glume)- and EMS-induced mutant (softglume) at 0, 5, and 10 days post-heading (DPH).
resultsMulti-factorial analysis identified 676 genes exhibiting significant developmental stage × glume type interactions, highlighting 5 DPH as a critical temporal window for trait establishment. Weighted gene co-expression network analysis (WGCNA) revealed a strongly correlated module (r = 0.92) that functions as the core transcriptional regulon underlying glume hardness. This module drives a dual-layered structural reinforcement program. Coordinated upregulation of CAD (Cinnamyl alcohol dehydrogenase) and COMT (Caffeic acid O-methyltransferase) in the phenylpropanoid pathway promotes lignin deposition, increasing mechanical rigidity, while activation of cuticle biosynthesis, lipid modification, and glycine-rich protein genes strengthens the epidermal barrier. This coordinated process is regulated by MYB and MIKC_MADS transcription factors acting as central hubs, and the co-enrichment of flavonoid biosynthesis and photoprotection pathways indicates that glume hardness is linked to integrated structural and chemical defense mechanisms.
conclusionTogether, these findings delineate the molecular and temporal architecture of glume persistence in SHW. The identified transcriptional regulators provide potential genetic targets f to separate the tenacious glume phenotype from beneficial wild alleles, thereby facilitating the improvement of threshing efficiency without compromising adaptive traits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.